feed,title,long_url,short_url
Benzinga,"NMI Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results",https://www.benzinga.com/pressreleases/21/02/g19687581/nmi-holdings-inc-reports-fourth-quarter-and-full-year-2020-financial-results,https://j.mp/3jYaDCe
Benzinga,"Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021",https://www.benzinga.com/pressreleases/21/02/g19687579/pulmonx-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-2-2021,https://j.mp/3aqweQx
Benzinga,Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update,https://www.benzinga.com/pressreleases/21/02/g19687578/nurix-therapeutics-reports-fourth-quarter-and-fiscal-year-2020-financial-results-and-provides-a-co,https://j.mp/3qvGXyO
Benzinga,CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.benzinga.com/pressreleases/21/02/g19687577/crispr-therapeutics-provides-business-update-and-reports-fourth-quarter-and-full-year-2020-financi,https://j.mp/3qs5VyY
Benzinga,"Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021",https://www.benzinga.com/pressreleases/21/02/g19687576/ziopharm-oncology-to-report-fourth-quarter-and-full-year-2020-financial-results-and-host-webcast-o,https://j.mp/3psz0sA
Benzinga,HealthEquity Announces Commencement of Proposed Offering of Common Stock,https://www.benzinga.com/pressreleases/21/02/g19687575/healthequity-announces-commencement-of-proposed-offering-of-common-stock,https://j.mp/3be08qo
Benzinga,Micron Appoints Linnie Haynesworth to Its Board of Directors,https://www.benzinga.com/pressreleases/21/02/g19687574/micron-appoints-linnie-haynesworth-to-its-board-of-directors,https://j.mp/3deeVnA
Benzinga,EMCORE Announces Closing of $35.9 Million Public Offering of Common Stock,https://www.benzinga.com/pressreleases/21/02/g19687573/emcore-announces-closing-of-35-9-million-public-offering-of-common-stock,https://j.mp/3dwIwJd
Benzinga,Y-mAbs Announces Proposed Public Offering of Common Stock,https://www.benzinga.com/pressreleases/21/02/g19687572/y-mabs-announces-proposed-public-offering-of-common-stock,https://j.mp/3psLdOb
Benzinga,Lumos Pharma Announces Changes to its Board of Directors,https://www.benzinga.com/pressreleases/21/02/g19687571/lumos-pharma-announces-changes-to-its-board-of-directors,https://j.mp/3dlamYK
Benzinga,"iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.benzinga.com/pressreleases/21/02/g19687570/icad-to-participate-in-the-btig-virtual-medtech-digital-health-life-science-diagnostic-tools-confe,https://j.mp/3rTvCIW
Benzinga,Cornerstone OnDemand Announces Fourth Quarter and Fiscal Year 2020 Financial Results,https://www.benzinga.com/pressreleases/21/02/b19687584/cornerstone-ondemand-announces-fourth-quarter-and-fiscal-year-2020-financial-results,https://j.mp/3pkDHos
Benzinga,"Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021",https://www.benzinga.com/pressreleases/21/02/b19687583/xencor-to-host-fourth-quarter-and-full-year-2020-financial-results-webcast-and-conference-call-on-,https://j.mp/3jYaHSu
Benzinga,TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock,https://www.benzinga.com/pressreleases/21/02/b19687582/therapeuticsmd-announces-closing-of-its-underwritten-public-offering-of-common-stock,https://j.mp/3poMJ3B
Benzinga,KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares,https://www.benzinga.com/pressreleases/21/02/b19687580/kalvista-pharmaceuticals-announces-the-closing-of-its-upsized-public-offering-of-common-stock-and-,https://j.mp/2NBFLuT
